Intrauterine-like growth rates can be achieved with premixed parenteral nutrition solution in preterm infants

Jacques Rigo1, Thibault Senterre

  • 1University of Liege, Liege, Belgium.

The Journal of Nutrition
|October 11, 2013
PubMed

Insights

Early aggressive parenteral nutrition (PN) using ready-to-use solutions improves growth in preterm infants. This approach reduces nutritional deficits and postnatal growth restriction in neonatal intensive care units.

Area of Science:

  • Neonatology
  • Pediatric Nutrition
  • Intensive Care Medicine

Background:

  • Neonatal intensive care units face challenges with infant growth failure.
  • Early "aggressive" parenteral nutrition (PN) is recommended to meet preterm infant needs.
  • Nutritional practices and adherence to guidelines vary across hospitals.

Purpose of the Study:

  • To evaluate two ready-to-use (RTU), premixed parenteral solutions (PSs) for preterm infants.
  • To assess the impact of these PSs on nutritional intake and growth outcomes.
  • To determine if RTU premixed PSs reduce early nutritional deficits and postnatal growth restriction.

Main Methods:

  • Prospective evaluation of two RTU premixed PSs: a hospital pharmacy binary PS and a commercial 3-chamber bag.
  • Assessment of nitrogen and energy delivery from the first day of life.
  • Comparison of nutritional intakes with international guidelines and growth outcomes.

Main Results:

  • Premixed PSs provide recommended nitrogen and energy intakes for preterm infants.
  • These solutions reduce or eliminate early cumulative nutritional deficits in very-low-birth-weight infants.
  • The use of RTU premixed PSs helps avoid postnatal growth restriction.

Conclusions:

  • RTU premixed parenteral solutions are effective in meeting the nutritional needs of preterm infants.
  • These solutions support optimal growth and reduce the incidence of growth restriction.
  • Balanced PN with amino acids, energy, minerals, and electrolytes from day one is crucial for preterm infants.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
2.0K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
2.0K
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
170
Routes of Drug Administration: Parenteral01:25

Routes of Drug Administration: Parenteral

The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
3.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
982
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
562